GDF15 and fatty liver disease: In diet-induced MASH mice, GDF15 ablation exacerbates hepatic steatosis, inflammation, fibrosis, and liver injury, while transgenic GDF15 expression alleviates these phenotypes and metabolic deterioration (Kim et al., 2018; Wang et al., 2022b).